Theme · live manifest · live theme JSON
Biotech '25: Commercial / Late Stage
5 tickers · $21.27B total market cap
Group: Biotech
Biotech '25: Commercial / Late Stage tracks 5 publicly listed stocks in this theme: APLS, ARQT, CYTK, HALO, SPRY. See the constituent table for details.
Constituents
Build 20260520T081747
| Company | Previous Quarter Report Date | Next Expected Report Date | Last Quarter Earnings Move % | Earnings Move % | Intra-Quarter Move % | Since Last Report % | Market cap | Weight |
|---|---|---|---|---|---|---|---|---|
Cytokinetics, IncorporatedCYTK | 05/05/2026 (AMC) | 05/05/2026 (AMC) | -10.66% | 13.31% | 23.09% | 2.15% | $9.51B | 20.0000 |
Halozyme Therapeutics, Inc.HALO | 05/11/2026 (AMC) | 05/11/2026 (AMC) | -10.49% | 10.62% | -7.82% | -3.10% | $8.15B | 20.0000 |
Arcutis Biotherapeutics, Inc.ARQT | 05/06/2026 (AMC) | 05/06/2026 (AMC) | -0.15% | -11.78% | -10.38% | -5.61% | $2.44B | 20.0000 |
ARS Pharmaceuticals, Inc.SPRY | 05/15/2026 (AMC) | 05/15/2026 (AMC) | -7.40% | -6.49% | -11.40% | -3.43% | $712.0M | 20.0000 |
Apellis Pharmaceuticals, Inc.APLS | 05/07/2026 (AMC) | 05/07/2026 (AMC) | -2.21% | -0.22% | 89.51% | 0.00% | $452.8M | 20.0000 |
| Average | -6.18% | 1.09% | 16.60% | -2.00% | $4.25B | 20.0000 | ||
| Median | -7.40% | -0.22% | -7.82% | -3.10% | $2.44B | 20.0000 | ||
| Std Dev | 4.29% | 9.64% | 38.64% | 2.74% | $3.82B | 0.0% | ||
| Min | -10.66% | -11.78% | -11.40% | -5.61% | $452.8M | 20.0000 | ||
| Max | -0.15% | 13.31% | 89.51% | 2.15% | $9.51B | 20.0000 | ||
| % Positive Tickers | 0.00% | 40.00% | 40.00% | 20.00% |
* Provisional value: before LstRpt% reaches its 2-day post-report lock window (BMO/AMC adjusted), EarningsPerf is calculated from current vs pre-report and then locks to final LstRpt%.